Methamphetamine activates reward circuitry in drug naïve human subjects

Neuropsychopharmacology

Volumn 29, Issue 9, 2004, Pages 1715-1722

  Völlm, Birgit A ^a,d   De Araujo, Ivan E ^b   Cowen, Philip J ^a   Rolls, Edmund T ^b   Kringelbach, Morten L ^c   Smith, Katharine A ^a   Jezzard, Peter ^c   Heal, Ronald J ^c   Matthews, Paul M ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Amphetamine; Dopamine; fMRI; Human; Orbitofrontal cortex; Psychological effect

Indexed keywords

METHAMPHETAMINE;

ADDICTION; ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; DATA ANALYSIS; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HYPOTHESIS; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PRIORITY JOURNAL; REINFORCEMENT; REWARD;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; NERVE NET; REWARD; SINGLE-BLIND METHOD;

EID: 4344604541     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300481     Document Type: Article

References (43)

1. Anderson AK, Christoff K, Stappen I, Panitz D, Ghahremani DG, Glover G et al (2003). Dissociated neural representations of intensity and valence in human olfaction. Nat Neurosci 6: 196-202.
2. Blood AJ, Zatorre RJ, Bermudez P, Evans AC (1999). Emotional responses to pleasant and unpleasant music correlate with activity in paralimbic brain regions. Nat Neurosci 2: 382-387.
3. Breiter HC, Rosen BR (1999). Functional magnetic resonance imaging of brain reward circuitry in the human. Ann NY Acad Sci 877: 523-547.
4. Breiter HC, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM et al (1997). Acute effects of cocaine on human brain activity and emotion. Neuron 19: 591-611.
5. Cardinal R, Parkinson JA, Hall J, Everitt BJ (2002). Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26: 321-352.
6. Cavada C, Company T, Tejedor J, Cruz-Rizzolo RJ, Reinoso-Suarez F (2000). The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb Cortex 10: 220-242.
7. Collins DL, Neelin P, Peters TM, Evans AC (1994). Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18: 192-205.
8. de Araujo IE, Kringelbach ML, Rolls ET, McGlone F (2003). Human cortical responses to water in the mouth, and the effects of thirst. J Neurophysiol 90: 1865-1876.
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC.
10. Friston K, Jezzard P, Turner R (1994). Analysis of functional MRI time-series. Hum Brain Mapp 1: 153-171.
11. Goldstein RZ, Volkow ND (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642-1652.
12. Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning D, Thelen B, Spitzer M et al (1999). Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology 20: 565-581.
13. Hariri AR, Mattay VS, Tessitore A, Fera F, Smith WG, Weinberger DR (2002). Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 27: 1036-1040.
14. Hurd YL, Suzuki M, Sedvall GC (2001). D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J Chem Neuroanat 22: 127-137.
15. Kahn DA, Prohovnik I, Luca LR, Sackeim (1989). Dissociated effects of amphetamine on arousal and cortical blood flow in humans. Biol Psychiatry 25: 755-767.
16. Kleinschmidt A, Bruhn H, Kruger G, Merboldt KD, Stoppe G, Frahm J (1999). Effects of sedation, stimulation, and placebo on cerebral blood oxygenation: a magnetic resonance neuroimaging study of psychotropic drug action. NMR Biomed 12: 286-292.
17. Kringelbach M, O'Doherty J, Rolls ET, Andrews C (2003). Activation of human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb Cortex 13: 1064-1071.
18. McTavish SFB, McPherson MH, Harmer CJ, Clark L, Sharp T, Goodwin GM et al (2001). Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179: 356-360.
19. McTavish SFB, McPherson MH, Sharp T, Cowen PF (1999). Attenuation of some subjective effects of amphetamine following tyrosine depletion. J Psychopharmacol 13: 144-147.
20. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285-300.
21. Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R et al (2000). Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12: 268-275.
22. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF et al (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191.
23. Murray JB (1998). Psychophysiological aspects of amphetamine abuse. J Psychol 132: 227-237.
24. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C (2001). Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 4: 95-102.
25. O'Doherty J, Winston J, Critchley H, Perrett D, Burt DM, Dolan RJ (2003). Beauty in a smile: the role of medial orbitofrontal cortex in facial attractiveness. Neuropsychologia 41: 147-155.
26. Parkinson JA, Olmstead MC, Burns LH, Robbins TW, Everitt BJ (1999). Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci 19: 2401-2411.
27. Phillips AGMF, Rolls ET (1981). Intra-cerebral self-administration of amphetamine by rhesus monkeys. Neurosci Lett 24: 81-86.
28. Redoute J, Stoleru S, Gregoire MC, Costes N, Cinotti L, Lavenne F et al (2000). Brain processing of visual sexual stimuli in human males. Hum Brain Mapp 11: 162-177.
29. Rolls ET (1999). The Brain and Emotion. Oxford University Press: Oxford.
30. Rolls ET (2000). The orbitofrontal cortex and reward. Cereb Cortex 10: 284-294.
31. Rolls ET, Kringelbach ML, de Araujo IE. (2003b). Different representations of pleasant and unpleasant odours in the human brain. Eur J Neurosci 18: 695-703.
32. Rolls ET, O'Doherty J, Kringelbach ML, Francis S, Bowtell R, McGlone F (2003a). Representations of pleasant and painful touch in the human orbitofrontal and cingulate cortices. Cereb Cortex 13: 308-317.
33. Rolls ET, Sienkiewicz ZJ, Yaxley S. (1989). Hunger modulates the responses to gustatory stimuli of single neurons in the caudolateral orbitofrontal cortex of the macaque monkey. Eur J Neurosci 1: 53-60.
34. Talairach J, Tournoux P (1988). Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme.
35. Taylor JR, Robbins TW (1986). 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens D-amphetamine. Psychopharmacology 90: 390-397.
36. Uftring SJ, Wachtel SR, Chu D, McCandless D, Levin DN, de Wit H (2001). An fMRI study of the effect of amphetamine on brain activity. Neuropsychopharmacology 25: 925-935.
37. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021.
38. Volkow ND, Fowler JS (2000). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10: 318-325.
39. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ (2002). Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 78: 610-624.
40. Vollenweider FX, Maguire RP, Leenders KL, Mathys K, Angst J (1998). Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res 83: 149-162.
41. Wilson JL, Jenkinson , de Araujo I, Kringelbach M, Rolls E, Jezzard P (2000). Fast, fully automated global and local magnetic field optimisation for fMRI of the human brain. Neuroimage 17: 967.
42. Woolverton WL, Cervo L, Johanson CE (1984). Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 21: 737-741.
43. Worsley KJ, Marrett P, Neelin AC, Friston KJ, Evans AC (1996). A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4: 58-73.